Company: HURA
Filing Date: 2025-05-23
Form Type: 424B3
Source: 0001193125-25-125499
Chunk: 952

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-23
Form: 424B3
Chunk 952
---
 the 2023 Company Warrants identified on
of the Company Disclosure Letter not automatically exercised or cancelled pursuant to their terms immediately prior to the Effective Time of the Mergers, shall enter into agreements satisfactory to Parent to
provide for the exercise or termination of such 2023 Company Warrants prior to the Closing (the “”).

(g) . The Estimated Net Working Capital Deficit, if any, shall not be greater than Twelve Million
Dollars ($12,000,000).

(h) . All of the members of the Company Board and
the Company’s executive officers, including each of their Affiliates which hold Shares will have executed and delivered Lock-Up Agreements, substantially in the form attached hereto as .

(i) . As of immediately prior to
the Effective Time, the Company and its Subsidiaries will have only Program Assets, cash, cash equivalents, and prepaid expenses (and for the avoidance of doubt, will not have any material assets that are not Program Assets (“”)) and the completion of the disposition or dissolution of Kineta Chronic Pain, LLC, a Washington limited liability company and Yumanity, Inc., a Delaware corporation will have occurred.

(j) . All litigation or disputes disclosed in of the Company Disclosure Letter
shall be resolved or otherwise cease to be pending as of the Closing.

Section 6.3 . The obligations of the Company to effect the Mergers and otherwise consummate the transactions to be consummated at the Closing are subject to the satisfaction or the written waiver by the Company, at or prior to the Closing, of
each of the following additional conditions:

(a) . Each of the Parent Fundamental Representations shall
have been true and correct in all material respects as of the date of this Agreement and shall be true and correct in all material respects on and as of the Closing Date with the same force and effect as if made on and as of such date (except to the
extent such representations and warranties are specifically made as of a particular date, in which case such representations and warranties shall be true and correct in all material respects as of such date). The Parent Capitalization
Representations shall have been true and correct in all respects as of the date of this Agreement and shall be true and correct on and as of the Closing Date with the same force and effect as if made on and as of such date, except, in each case,
(y) for such inaccuracies which are de minimis, individually or in the aggregate or (z) for those representations and